JohnTCarpenterJr.MD

PubMed

• Less Toxic Chemotherapy in Locally Advanced Breast Cancer.
  John T. Carpenter, Andres Forero, Carla I. Falkson, Lisle Nabell, Jennifer F. De Los Santos, Helen Krontiras, Kirby I. Bland, Yufeng Li, Sejong Bae> ;Southern Medical Journal. 2020 Nov 1
• 14 citations
  Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008.
  Roisin M. Connolly, Mary Jo Fackler, Zhe Zhang, Xian C. Zhou, Matthew P. Goetz, Judy C. Boughey, Bridget Walsh, John T. Carpenter, Anna Maria Storniolo, Stanley Watkin...> ;Breast Cancer Research and Treatment. 2018 Jan 1
• 45 citations
  TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases
  Carey K. Anders, Allison M. Deal, Vandana G. Abramson, Minetta C. Liu, Anna Maria Storniolo, John T. Carpenter, Shannon Puhalla, Rita Nanda, Amal Melhem-Bertrandt, Nan...> ;Breast Cancer Research and Treatment. 2014 Jul 8
• 1 citations
  How do I recommend extended adjuvant hormonal therapy
  Amitkumar Mehta, John T. Carpenter> ;Current Treatment Options in Oncology. 2014 Mar 1
• 305 citations
  Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL—CALGB 150007/150012, ACRIN 6657
  Laura J. Esserman, Donald A. Berry, Angela DeMichele, Lisa A. Carey, Sarah E. Davis, Meredith Buxton, Cliff Hudis, Joe W. Gray, Charles M. Perou, Christina Yau, Chad A...> ;Journal of Clinical Oncology. 2012 Sep 10
• 6 citations
  Nocardia neocaldoniensis as a Cause of Skin and Soft Tissue Infection
  Travea McGhie, Robert Fader, John T. Carpenter, Barbara A. Brown-Elliott, Ravikiran Vasireddy, Richard J. Wallace> ;Journal of Clinical Microbiology. 2012 Sep 1
• 247 citations
  Chemotherapy response and recurrence-free survival in Neoadjuvant breast cancer depends on biomarker profiles: Results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACR...
  Laura J. Esserman, Donald A. Berry, Maggie C.U. Cheang, Christina Yau, Charles M. Perou, Lisa A. Carey, Angela DeMichele, Joe W. Gray, Kathleen Conway-Dorsey, Marc E. ...> ;Breast Cancer Research and Treatment. 2012 Apr 1
• 28 citations
  Accuracy of breast magnetic resonance imaging in predicting pathologic response in patients treated with neoadjuvant chemotherapy.
  Jennifer F. De Los Santos, W K Bernreuter, Kimberly S. Keene, Helen Krontiras, John T. Carpenter, Kirby I. Bland, Alan B. Cantor, Andres Forero> ;Clinical Breast Cancer. 2011 Oct 1
• 10 citations
  Dose Effects of Relaxation Practice on Immune Responses in Women Newly Diagnosed With Breast Cancer: An Exploratory Study
  Duck Hee Kang, Traci McArdle, Na-Jin Park, Michael T. Weaver, Barbara A. Smith, John T. Carpenter> ;Oncology Nursing Forum. 2011 Apr 29
• 26 citations
  Pilot trial of preoperative (neoadjuvant) letrozole in combination with bevacizumab in postmenopausal women with newly diagnosed estrogen receptor- or progesterone rec...
  Andres Forero-Torres, Mansoor N. Saleh, Janice A. Galleshaw, Cheryl F. Jones, Jatin J. Shah, I. Percent, Lisle Nabell, John T. Carpenter, Carla I. Falkson, Helen Kront...> ;Clinical Breast Cancer. 2010 Aug 1
• 6 citations
  Estradiol in breast cancer treatment: reviving the past.
  Pamela N. Munster, John T. Carpenter> ;JAMA. 2009 Aug 19
• 5524 citations
  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
  O. Abe, R. Abe, K. Enomoto, K. Kikuchi, H. Koyama, H. Masuda, Y. Nomura, K. Sakai, K. Sugimachi, T. Tominaga, J. Uchino, M. Yoshida, J. L. Haybittle, C Davies, V. J. H...> ;Lancet. 2005 May 14
• 1101 citations
  Randomized Trial of Dose-Dense Versus Conventionally Scheduled and Sequential Versus Concurrent Combination Chemotherapy as Postoperative Adjuvant Treatment of Node-Po...
  Marc L. Citron, Donald A. Berry, Constance Cirrincione, Clifford A. Hudis, Eric P. Winer, William J. Gradishar, Nancy E. Davidson, Silvana Martino, Robert B. Livingsto...> ;Journal of Clinical Oncology. 2003 Apr 15
• 915 citations
  Improved Outcomes From Adding Sequential Paclitaxel but Not From Escalating Doxorubicin Dose in an Adjuvant Chemotherapy Regimen for Patients With Node-Positive Primar...
  I. Craig Henderson, Donald A. Berry, George D. Demetri, Constance Cirrincione, Lori J. Goldstein, Silvana Martino, James N. Ingle, M. Robert Cooper, Daniel F. Hayes, K...> ;Journal of Clinical Oncology. 2003 Mar 15
• 86 citations
  Decreased dihydropyrimidine dehydrogenase activity in a population of patients with breast cancer: implication for 5-fluorouracil-based chemotherapy.
  Zhihong Lu, Ruiwen Zhang, John T. Carpenter, Robert B. Diasio> ;Clinical Cancer Research. 1998 Feb 1
• 2 citations
  The use of anthracyclines in the adjuvant treatment of breast cancer.
  Elizabeth A. Lowenthal, John T. Carpenter> ;Cancer Treatment Reviews. 1995 May 1
• 76 citations
  Postsurgical adjuvant chemotherapy with or without radiotherapy in women with breast cancer and positive axillary nodes: a South-Eastern Cancer Study Group (SEG) trial
  Enrique Velez-Garcia, John T. Carpenter, Melvin R. Moore, Charles L. Vogel, Victor A. Marcial, Alfred Ketcham, Karan P. Singh, David Bass, Alfred A. Bartolucci, Richar...> ;European Journal of Cancer. 1992 Jan 1
• 185 citations
  Severe 5-fluorouracil toxicity secondary to dihydropyrimidine dehydrogenase deficiency. A potentially more common pharmacogenetic syndrome.
  Barry E. Harris, John T. Carpenter, Robert B. Diasio> ;Cancer. 1991 Aug 1
• 25 citations
  Epithelioid hemangioendothelioma: CT manifestations and possible linkage to vinyl chloride exposure.
  Myung S. Shin, John T. Carpenter, Kang-Jey Ho> ;Journal of Computer Assisted Tomography. 1991 May 1
• 72 citations
  Weight gain with breast cancer adjuvant treatment.
  Ellen G. Levine, James M. Raczynski, John T. Carpenter> ;Cancer. 1991 Apr 1
• 17 citations
  The pathogenesis and clinical significance of cytologically detectable oral Candida in acute leukemia
  Brad Rodu, John T. Carpenter, Marsha R. Jones> ;Cancer. 1988 Nov 1
• 15 citations
  A randomized comparison of haloperidol plus dexamethasone versus prochlorperazine plus dexamethasone in preventing nausea and vomiting in patients receiving chemothera...
  L Silvey, John T. Carpenter, Richard H. Wheeler, Jeannette Y. Lee, C Conolley> ;Journal of Clinical Oncology. 1988 Sep 1
• 2 citations
  Phase I-II study of cisplatin, VP-16, MGBG, mitomycin, and vinblastine with radiation therapy for non-small-cell lung cancer.
  Elizabeth S. Christian, Marshall Schreeder, Merle M. Salter, Suzanne B. Stephens, John T. Carpenter, Richard H. Wheeler> ;American Journal of Clinical Oncology. 1988 Aug 1
• 2 citations
  Phase II evaluation of teniposide (VM-26) in metastatic breast carcinoma. A Southeastern Cancer Study Group trial
  Edwin B. Cox, Charles L. Vogel, John T. Carpenter, Marilyn Raney> ;Investigational New Drugs. 1988 Apr 1
• Multiple drug intensification after cyclophosphamide, doxorubicin, and 5-fluorouracil (CAF) induction in metastatic breast cancer: a Southeastern Cancer Study Group ph...
  Vogel Cl, Marilyn Raney, John T. Carpenter> ;Cancer Treatment Reports. 1987 Dec 1
• Join now to see all